Recurrent systemic embolic events with valve prosthesis

J. Acar, M. Enriquez-Sarano, E. Farah, R. Kassab, P. Tubiana, V. Roger

Research output: Contribution to journalArticle

15 Scopus citations


Among 1436 patients who underwent valve replacement, the 400 first cases were studied to assess the features of recurrent systemic embolic event. The mean follow-up was 87 months. Three groups of patients were compared: group A - 289 patients without any thromboembolic event (72.25%); group B - 78 patients with only one embolic event (19.5%); group C - 33 patients with several embolic events (8.25%). The frequency of recurrence was high; one patient out of three (linearized mean 8.9% in group C considering only one recurrence, vs 3.8% in group B). The recurrence have the same location in 45% of patients. The consequences of these embolisms are serious; each event has a 30 to 40% risk of death or major disability. Four variables seem statistically to promote the occurrence of embolic events: mitral prostheses, pre-operative fibrillation, left atrial enlargement, poor anticoagulant therapy. 54 months after thromboembolism vs 20% with adequate therapy. Twenty-six patients of groups B and C had a pathological study of prostheses. Thrombosis of the prostheses was found in 12 out of 18 patients in group B and in 7 out of 8 patients; in group C. Strict observance of anticoagulant therapy is the better way to prevent thromboembolism and especially recurrences. A reoperation is sometimes necessary. Valve re-replacement was performed in 27 cases out of 1436 patients.

Original languageEnglish (US)
Pages (from-to)33-38
Number of pages6
JournalEuropean heart journal
Issue numberSUPPL. D
StatePublished - Jan 1 1984

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Recurrent systemic embolic events with valve prosthesis'. Together they form a unique fingerprint.

  • Cite this